Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathak SR, Soud FA, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, Brooks JT; TDF2 Study Group. Thigpen MC, et al. Among authors: rose ce. N Engl J Med. 2012 Aug 2;367(5):423-34. doi: 10.1056/NEJMoa1110711. Epub 2012 Jul 11. N Engl J Med. 2012. PMID: 22784038 Free article. Clinical Trial.
Antiretroviral preexposure prophylaxis for HIV prevention.
Thigpen MC, Rose CE, Paxton LA. Thigpen MC, et al. Among authors: rose ce. N Engl J Med. 2013 Jan 3;368(1):82-3. doi: 10.1056/NEJMc1210464. N Engl J Med. 2013. PMID: 23281985 No abstract available.
Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.
Grohskopf LA, Chillag KL, Gvetadze R, Liu AY, Thompson M, Mayer KH, Collins BM, Pathak SR, Oʼhara B, Ackers ML, Rose CE, Grant RM, Paxton LA, Buchbinder SP. Grohskopf LA, et al. Among authors: rose ce. J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):79-86. doi: 10.1097/QAI.0b013e31828ece33. J Acquir Immune Defic Syndr. 2013. PMID: 23466649 Clinical Trial.
Risk behaviors and risk factors for HIV infection among participants in the Bangkok tenofovir study, an HIV pre-exposure prophylaxis trial among people who inject drugs.
Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, Gvetadze RJ, Kittimunkong S, Curlin ME, Worrajittanon D, McNicholl JM, Paxton LA, Choopanya K; Bangkok Tenofovir Study Group. Martin M, et al. PLoS One. 2014 Mar 25;9(3):e92809. doi: 10.1371/journal.pone.0092809. eCollection 2014. PLoS One. 2014. PMID: 24667938 Free PMC article. Clinical Trial.
Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007-2010.
Kebaabetswe PM, Stirratt MJ, McLellan-Lemal E, Henderson FL, Gray SC, Rose CE, Williams T, Paxton LA. Kebaabetswe PM, et al. Among authors: rose ce. AIDS Behav. 2015 May;19(5):758-69. doi: 10.1007/s10461-014-0891-z. AIDS Behav. 2015. PMID: 25186785 Free PMC article. Clinical Trial.
190 results